Timms JM - Search Results

1

Low incidence of human herpesvirus 8 in stem cell collections from myeloma patients.

Cull GM, Carter GI, Timms JM, Thomson BJ, Russell NH, Haynes AP. Cull GM, et al. Among authors: timms jm. Bone Marrow Transplant. 1999 Apr;23(8):759-61. doi: 10.1038/sj.bmt.1701674. Bone Marrow Transplant. 1999. PMID: 10231136

2

Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8.

Cull GM, Timms JM, Haynes AP, Russell NH, Irving WL, Ball JK, Thomson BJ. Cull GM, et al. Among authors: timms jm. Br J Haematol. 1998 Mar;100(4):793-6. doi: 10.1046/j.1365-2141.1998.00671.x. Br J Haematol. 1998. PMID: 9531351 Free article.

3

Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.

Owsianka AM, Timms JM, Tarr AW, Brown RJ, Hickling TP, Szwejk A, Bienkowska-Szewczyk K, Thomson BJ, Patel AH, Ball JK. Owsianka AM, et al. Among authors: timms jm. J Virol. 2006 Sep;80(17):8695-704. doi: 10.1128/JVI.00271-06. J Virol. 2006. PMID: 16912317 Free PMC article.

4

Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma.

Junying J, Herrmann K, Davies G, Lissauer D, Bell A, Timms J, Reynolds GM, Hubscher SG, Young LS, Niedobitek G, Murray PG. Junying J, et al. Virology. 2003 Feb 15;306(2):236-43. doi: 10.1016/s0042-6822(02)00027-2. Virology. 2003. PMID: 12642097 Free article.

5

Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome.

Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, Timms J, Rowlands D, McConkey C, Reynolds GM, Ghataura S, England D, Caroll R, Young LS. Murray PG, et al. Cancer Res. 2003 May 1;63(9):2338-43. Cancer Res. 2003. PMID: 12727860

6

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

Tarr AW, Owsianka AM, Timms JM, McClure CP, Brown RJ, Hickling TP, Pietschmann T, Bartenschlager R, Patel AH, Ball JK. Tarr AW, et al. Among authors: timms jm. Hepatology. 2006 Mar;43(3):592-601. doi: 10.1002/hep.21088. Hepatology. 2006. PMID: 16496330

7

Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma.

Timms JM, Bell A, Flavell JR, Murray PG, Rickinson AB, Traverse-Glehen A, Berger F, Delecluse HJ. Timms JM, et al. Lancet. 2003 Jan 18;361(9353):217-23. doi: 10.1016/S0140-6736(03)12271-4. Lancet. 2003. PMID: 12547545

8

Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance.

Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N, Khan N, Palendira U, Leese AM, Timms JM, Bell AI, Buckley CD, Rickinson AB. Hislop AD, et al. Among authors: timms jm. J Clin Invest. 2005 Sep;115(9):2546-55. doi: 10.1172/JCI24810. Epub 2005 Aug 18. J Clin Invest. 2005. PMID: 16110323 Free PMC article.

9

Acute liver failure secondary to opportunistic viral infection in adult solid organ transplant recipients.

Claridge LC, Dobson C, Kanji H, Neil D, Timms JM, Holt AP. Claridge LC, et al. Among authors: timms jm. QJM. 2012 Sep;105(9):879-82. doi: 10.1093/qjmed/hcr117. Epub 2011 Jul 19. QJM. 2012. PMID: 21771853 No abstract available.

10

Successful treatment of invasive cavernous sinus aspergillosis with oral itraconazole monotherapy.

Browning AC, Sim KT, Timms JM, Vernon SA, McConachie NS, Allibone R, Jones NS. Browning AC, et al. Among authors: timms jm. J Neuroophthalmol. 2006 Jun;26(2):103-6. doi: 10.1097/01.wno.0000223267.48447.52. J Neuroophthalmol. 2006. PMID: 16845309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters